Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Telephone And Data Systems VV Pref | TDS-V | Jan 15, 2025 | 18.70 | +2.63 |
Telesat | TSAT | Jan 15, 2025 | 15.40 | +4.69 |
Telix Pharmaceuticals | TLX | Jan 15, 2025 | 15.61 | 0.00 |
Telomir Pharmaceuticals | TELO | Jan 15, 2025 | 4.84 | +5.68 |
Telos | TLS | Jan 15, 2025 | 3.32 | +3.75 |
Telus | TU | Jan 15, 2025 | 13.69 | -0.15 |
Telus International | TIXT | Jan 15, 2025 | 3.35 | +1.21 |
Tempest Therapeutics | TPST | Jan 15, 2025 | 0.89 | -2.83 |
Templeton Dragon Fund | TDF | Jan 15, 2025 | 8.31 | +0.85 |
Templeton Emerging Markets | TEI | Jan 15, 2025 | 5.26 | +1.54 |
Templeton Emerging Markets Fund | EMF | Jan 15, 2025 | 12.00 | +1.01 |
Tempur Sealy International | TPX | Jan 15, 2025 | 57.64 | +1.66 |
Tempus AI | TEM | Jan 15, 2025 | 34.92 | +9.71 |
Tenable | TENB | Jan 15, 2025 | 40.52 | +3.76 |
Tenaris ADR | TS | Jan 15, 2025 | 39.41 | +0.46 |
Tenax Therapeutics | TENX | Jan 15, 2025 | 6.48 | +0.78 |
Tenaya Therapeutics | TNYA | Jan 15, 2025 | 1.47 | +2.80 |
Tencent Music Entertainment A ADR | TME | Jan 15, 2025 | 10.50 | +0.48 |
Tenet Healthcare | THC | Jan 15, 2025 | 130.03 | +1.88 |
Tennant | TNC | Jan 15, 2025 | 84.06 | +0.91 |
Tennessee Valley Authority C Pref | TVC | Jan 15, 2025 | 22.79 | +0.22 |
Tennessee Valley Authority E Pref | TVE | Jan 15, 2025 | 22.41 | +0.27 |
Tenon Medical | TNON | Jan 15, 2025 | 1.69 | +1.20 |
Teradata | TDC | Jan 15, 2025 | 31.15 | +1.70 |
Teradyne | TER | Jan 15, 2025 | 134.93 | +0.56 |
TeraWulf | WULF | Jan 15, 2025 | 6.18 | +10.95 |
Terex | TEX | Jan 15, 2025 | 46.89 | +2.25 |
Ternium ADR | TX | Jan 15, 2025 | 29.28 | +1.91 |
Terns Pharmaceuticals | TERN | Jan 15, 2025 | 4.63 | +1.31 |
Terreno Realty | TRNO | Jan 15, 2025 | 59.74 | +0.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.